184 related articles for article (PubMed ID: 32488123)
1. ROS-Mediated Apoptotic Cell Death of Human Colon Cancer LoVo Cells by Milk δ-Valerobetaine.
D'Onofrio N; Cacciola NA; Martino E; Borrelli F; Fiorino F; Lombardi A; Neglia G; Balestrieri ML; Campanile G
Sci Rep; 2020 Jun; 10(1):8978. PubMed ID: 32488123
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and Anti-Inflammatory Activities of Buffalo Milk δ-Valerobetaine.
D'Onofrio N; Balestrieri A; Neglia G; Monaco A; Tatullo M; Casale R; Limone A; Balestrieri ML; Campanile G
J Agric Food Chem; 2019 Feb; 67(6):1702-1710. PubMed ID: 30661355
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer Apoptosis Induced by Dietary δ-Valerobetaine Involves PINK1/Parkin Dependent-Mitophagy and SIRT3.
D'Onofrio N; Martino E; Mele L; Colloca A; Maione M; Cautela D; Castaldo D; Balestrieri ML
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360883
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Effect of Dietary Betaines on SIRT1-Mediated Apoptosis in Human Oral Squamous Cell Carcinoma Cal 27.
D'Onofrio N; Mele L; Martino E; Salzano A; Restucci B; Cautela D; Tatullo M; Balestrieri ML; Campanile G
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32878301
[TBL] [Abstract][Full Text] [Related]
5. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives.
Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O
Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852
[TBL] [Abstract][Full Text] [Related]
6. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
7. A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells.
Kim AD; Kang KA; Kim HS; Kim DH; Choi YH; Lee SJ; Kim HS; Hyun JW
Cell Death Dis; 2013 Aug; 4(8):e750. PubMed ID: 23907464
[TBL] [Abstract][Full Text] [Related]
8. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.
Xie CM; Chan WY; Yu S; Zhao J; Cheng CH
Free Radic Biol Med; 2011 Oct; 51(7):1365-75. PubMed ID: 21763418
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells.
Song JD; Lee SK; Kim KM; Park SE; Park SJ; Kim KH; Ahn SC; Park YC
J Biochem Mol Toxicol; 2009; 23(1):71-9. PubMed ID: 19202565
[TBL] [Abstract][Full Text] [Related]
10. beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells.
Huang L; Pardee AB
Mol Med; 1999 Nov; 5(11):711-20. PubMed ID: 10656873
[TBL] [Abstract][Full Text] [Related]
11. Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species-independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells.
Agarwal A; Kasinathan A; Ganesan R; Balasubramanian A; Bhaskaran J; Suresh S; Srinivasan R; Aravind KB; Sivalingam N
Nutr Res; 2018 Mar; 51():67-81. PubMed ID: 29673545
[TBL] [Abstract][Full Text] [Related]
12. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
13. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M
Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456
[TBL] [Abstract][Full Text] [Related]
14. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
Nagappan A; Lee WS; Yun JW; Lu JN; Chang SH; Jeong JH; Kim GS; Jung JM; Hong SC
PLoS One; 2017; 12(3):e0174591. PubMed ID: 28355296
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells.
Coker-Gurkan A; Arisan ED; Obakan P; Guvenir E; Unsal NP
Exp Cell Res; 2014 Oct; 328(1):87-98. PubMed ID: 25088259
[TBL] [Abstract][Full Text] [Related]
17. Methyl Sartortuoate Inhibits Colon Cancer Cell Growth by Inducing Apoptosis and G2/M-Phase Arrest.
Lan Q; Li S; Lai W; Xu H; Zhang Y; Zeng Y; Lan W; Chu Z
Int J Mol Sci; 2015 Aug; 16(8):19401-18. PubMed ID: 26287184
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.
Ling YH; Liebes L; Zou Y; Perez-Soler R
J Biol Chem; 2003 Sep; 278(36):33714-23. PubMed ID: 12821677
[TBL] [Abstract][Full Text] [Related]
19. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
Kannappan R; Ravindran J; Prasad S; Sung B; Yadav VR; Reuter S; Chaturvedi MM; Aggarwal BB
Mol Cancer Ther; 2010 Aug; 9(8):2196-207. PubMed ID: 20682650
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
